Researchers have designed a chemical phototherapy tool that when exposed to blue light damages an enzyme found in ...

Vertebrate lonesome kinase mediates a key interaction between neurons involved in injury-induced pain and helps explain ...

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.

Yanyan Zhao shares an insight into the preclinical development of a PET imaging tracer for catching Alzheimer’s disease ...

Scientists create a vaccine that shields against Crimean-Congo hemorrhagic fever within days and protects for over a year.

Researchers have developed a nanowire platform for studying astrocytes in their natural state, providing an insight into ...

Cornell (NY, USA) researchers have found that a new DNA sequencing technology can be used to study how transposons move ...

Colorectal cancer immunotherapy advances as Photobacterium angustum identified to selectively colonize tumors with minimal ...

Researchers have discovered how the GRP94 protein enlists the help of other proteins to shield it from glycosylation.

We spoke to Rebecca Goss to learn more about her precision molecular editing platform and its potential for drug development.

Using traditional animal models, drug development can take 10–15 years and cost over US$2 billion per approved drug, with over 90% of drugs that succeed in animal tests failing in human trials.

In this White Paper, MatTek, now part of Sartorius, details a highly differentiated 3D small-intestine tissue model that uses primary human stem cells to provide a more accurate alternative to animal ...